Personalised cancer vaccine slows melanoma recurrence, suggest topline phase III results Manufacturers Merck and Moderna said that the trial results demonstrate the “first positive phase III readout” for an individualised neoantigen therapy, as well as an mRNA-based cancer therapy.…
Local authorities advised to work with pharmacies to improve rural vaccination rates The Local Government Association said that community pharmacies should engage with local directors of public health to close gaps in vaccination coverage.…
Acne vulgaris: recognition and management An overview of the available treatment options for acne and how pharmacists can support patients with the condition.…
Psoriasis: presentation, diagnosis and management An overview of psoriasis, including its clinical features, diagnosis and management, as well as how pharmacists can optimise care.…
Test your knowledge of musculoskeletal conditions Our self-assessment quiz on musculoskeletal conditions covers the more common disorders that pharmacy staff may encounter, from arthritis and gout to carpal tunnel syndrome.…
JAK inhibitors: risks and safety principles An overview of the mechanism of action of Janus kinase inhibitors, as well as the risks and common side effects of their use in treating chronic inflammatory disorders.…
Health news round-up: puberty blockers, oral GLP-1s and inequalities in neonatal care A weekly summary of important developments in pharmacy and health news that you may have missed.…
NICE recommends first licensed treatment for vitiligo Guidance says that ruxolitinib cream can be used as treatment for vitiligo if other first-line treatments — such as including topical corticosteroids and light therapy — do not work.…
Health news round-up: GLP-1s for psoriasis, promise for people with cancer and pharmacogenomics A weekly summary of important developments in pharmacy and health news that you may have missed.…
Everything you need to know about mpox Following the identification of a new strain in England — and an ongoing global outbreak of the most severe subgroup of mpox — here is a summary of the latest information and best practice for pharmacy professionals.…
